ScoreComparison
Why is InMed Pharmaceuticals, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Flat results in Dec 25
- OPERATING CASH FLOW(Y) Lowest at USD -7.51 MM
- NET SALES(HY) At USD 1.94 MM has Grown at -18.35%
- ROCE(HY) Lowest at -97.2%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -75.74%, its profits have risen by 3.2%
4
Below par performance in long term as well as near term
- Along with generating -75.74% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is InMed Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
InMed Pharmaceuticals, Inc.
-75.48%
2.28
114.02%
S&P 500
13.68%
0.71
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
40.68%
EBIT Growth (5y)
-2.74%
EBIT to Interest (avg)
-9.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.50
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.40%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.26
EV to EBIT
0.52
EV to EBITDA
0.56
EV to Capital Employed
-1.36
EV to Sales
-0.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-79.94%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -3.76 MM
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -7.51 MM
NET SALES(HY)
At USD 1.94 MM has Grown at -18.35%
ROCE(HY)
Lowest at -97.2%
RAW MATERIAL COST(Y)
Grown by 92.36% (YoY
Here's what is working for InMed Pharmaceuticals, Inc.
Net Profit
Higher at USD -3.76 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Here's what is not working for InMed Pharmaceuticals, Inc.
Operating Cash Flow
Lowest at USD -7.51 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Net Sales
At USD 1.94 MM has Grown at -18.35%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Raw Material Cost
Grown by 92.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
